Welcome to the 4th Obesity & Weight Loss Drug Development Summit - the definitive industry-forum dedicated to redefining the standards of metabolic medicine by mastering precision treatment, preserving functional health, and navigating the high-stakes transition to next-generation oral and multi-agonist therapies. The obesity therapeutics market has entered a radical transformation. Driven by the unprecedented success of first-generation incretins, the landscape has reached […]

Across the West Coast, Expanded Access Programs are entering a new phase. More companies are launching EAPs earlier in development, supporting patients for longer durations, and extending access beyond the U.S. into increasingly complex global markets. What was once a reactive, exception-based activity is now a visible, repeatable function - bringing heightened expectations around governance, […]

The 6th mRNA‑Based Therapeutics Summit: Accelerating the Next Era of mRNA Medicines The global mRNA landscape is advancing at unprecedented speed, propelled by scientific breakthroughs and high‑impact biopharma investment. Recent acquisitions – including Eli Lilly and Orna, BMS and Orbital, AbbVie and Capstan, and BioNTech and CureVac – underscore the momentum behind emerging modalities such […]

The 5th Liquid Biopsy for Precision Oncology Summit East Coast returns as your laser-focused forum dedicated to the acceleration, progression and real-world adoption of liquid biopsies. Expect to unite with 100+ biopharma professionals from Pfizer, AbbVie, Takeda, AstraZeneca, GSK and more to redefine your clinical trial strategies and advance oncology drug development forward. Boasting a […]

The 6th Medical Device Software Development Summit returns this July in Boston and brings together the specialists who are defining how AI-driven and software-based medical devices are built, validated, and submitted in an increasingly complex regulatory environment. AI is accelerating innovation faster than traditional compliance models can keep up. FDA expectations for AI-enabled devices continue […]

As the only conference focused on neoantigens, the 9th International Neoantigen Summit returns to Amsterdam as the most timely and essential gathering for the field. As your only chance this year to learn about the latest clinical data in the field and address the full translational journey – from antigen identification and validation through to biomarker strategy, clinical trial […]

4th ADC Linker & Conjugation Summit Linking Chemistry to Clinical Success Through Better ADC Design When? July 28-30, 2026 Where? Boston, MA ADC development is evolving fast, with developers pushing beyond traditional cytotoxins into dual‑payload constructs, high‑DAR species, degrader–antibody conjugates, and next‑generation modalities. This surge in innovation is placing new pressure on linker architecture and […]

The 5th In Vivo Cell Engineering & Gene Editing Summit returns as the leading industry meeting dedicated to advancing the next generation of in vivo delivery platforms, gene editing tools, and translational strategies that support safe, precise, and scalable genetic medicines. Designed for scientists, technical leaders, and strategic decision-makers across biopharma, this summit provides a […]

The 3rd Annual Lab Ops & Facility Management for Biopharma West Summit is the West Coast’s dedicated meeting for Lab Operations and Facilities leaders who are being asked to do more with less while keeping scientists productive and R&D environments running at the highest standard. With tighter budgets, workforce fluctuations, and rapid pipeline shifts reshaping day-to-day priorities, […]

Taking place in Boston (August 17–19, 2026), the 5th Oligonucleotide Analytical Development & CMC Summit is a premier event dedicated to advancing analytical and CMC strategies for oligonucleotide therapeutics. Bringing together experts from Alnylam, Biogen, Ionis Pharmaceuticals, Amgen, and Avidity Biosciences, the meeting tackles key challenges in impurity control, complex chemistries, and scalable manufacturing. Attendees will gain insights into cutting-edge analytical tools including mass spectrometry and sequencing, alongside […]

The 6th Annual Oligonucleotides for CNS Summit USA returns to Boston on 19–21 August 2026, uniting 160+ leaders across pharma and biotech to accelerate the discovery, translation and clinical success of CNS‑targeted oligonucleotide therapies. As advances in RNA chemistry, delivery technologies and clinical evidence unlock previously undruggable CNS targets, this meeting is the industry’s most […]

As iPSC therapies transition from promise to clinical reality, the 6th iPSC Drug Development Summit arrives at a pivotal moment for biopharma leaders advancing next-generation cell therapies. Bringing together senior scientists, CMC experts, and decision-makers, this industry-focused meeting is dedicated exclusively to accelerating iPSC-based drug development from discovery through clinical translation and commercialization. This year’s […]

The Neuropsychiatric Drug Development Summit is the definitive meeting for biopharma leaders shaping the future of psychiatric R&D. At a time of renewed momentum in neuropsychiatry, this summit brings together senior decision‑makers to redefine how the industry translates science into successful, patient‑centred therapies. Across discovery, translational science, and clinical development, the agenda showcases the most […]

The First Industry‑Led Meeting Dedicated to Advancing Next‑Generation COPD Therapeutics The COPD Drug Development Summit is the first and only industry‑driven forum designed to accelerate meaningful innovation in chronic obstructive pulmonary disease. With the approval of the first biologic therapy marking a historic turning point, COPD R&D is entering a new era, one defined by […]

All eyes are on the next wave of CAR and TCR innovation. Success is no longer defined by clinical wins alone, but by smarter biological design, delivery strategies and manufacturing breakthroughs to lower COGs, expand patient access and secure commercial viability. With this, the 11th CAR-TCR Summit is making its hotly anticipated return to Boston, […]

The Measuring Patient Engagement Summit Europe is the leading industry forum dedicated to supporting biopharma in quantifying and demonstrating the true impact of patient engagement. As regulatory expectations rise and internal stakeholders demand a clearer return on investment, the need for robust, evidence-based frameworks has never been greater. This three-day summit brings together over 70 […]

The 5th Lipid Nanoparticles Development Summit Europe returns to Berlin, 23rd – 24th  September 2026, as the leading meeting for advancing LNP-enabled gene therapy delivery. Bringing together experts from BioNTech, AstraZeneca, Johnson & Johnson, Sanofi and AbbVie, the summit covers end-to-end LNP development, from formulation through to analytics, CMC and scalable manufacturing. Attendees will explore solutions to overcome liver tropism, enable extrahepatic delivery and engineer next-generation nanoparticle […]

The FDA has shown its' hand. The Plausible Mechanism Framework and new NGS safety guidance signal one thing clearly: regulators want genome editing therapies to reach patients. Biopharma is also pushing back with a surge of novel genome editing assets deployed in the last 2 years, targeting rare and prevalent diseases with scarce treatment options. […]

10th Anniversary Edition of the IPF Summit - September 29 – October 1, 2026 | Boston, MA For a decade, the IPF Summit has been the go-to, discussion-led forum uniting stakeholders across the pulmonary fibrosis ecosystem. In its 10th anniversary year, the stakes, and the opportunity, have never been higher. Following a wave of positive […]

AI is no longer a future concept in life sciences – it is actively reshaping how work gets done, how decisions are made, and how value is created. Yet most organisations are still navigating how to move from ambition to enterprise-wide execution. The Designing the AI-Enabled Life Sciences Workforce Summit Europe is the only forum built […]

The mRNA Process Development & CMC Summit returns for its 5th Anniversary, bringing together the brightest minds in mRNA development, manufacturing, and CMC strategy. As the field continues to evolve at pace, this milestone edition is your opportunity to connect, learn, and stay ahead of the curve with the leaders shaping the future of mRNA […]

Fueled by surging digital pathology partnerships, improved MRD sensitivity and high-plex single‑cell and multi‑omic profiling to breakthroughs, the precision medicine field is evolving rapidly. Building on this momentum, the 16th World Clinical Biomarkers & Companion Diagnostics Summit returns to Boston this fall, uniting 850+ senior stakeholders in the common goal of advancing timely, accessible and […]

Returning as the largest and definitive ADC congress, the 17th World ADC San Diego is THE one-stop bioconjugate shop, bringing together the global ADC community for an unparalleled amalgamation of case studies, development trends and networking opportunities to forge ADC innovation into differentiated, early-line patient outcomes. With 7 streams of end-to-end ADC content across Discovery […]

Early Access Programmes have evolved into a critical, but increasingly complex, part of drug development and launch strategy. What was once a reactive pathway is now a strategic lever shaping timelines, evidence generation, and patient access across global markets. The 5th Operationalise: Early Access Programmes Summit Europe is built for the teams responsible for turning […]

4th Covalent Drug Discovery & Development Summit (October 20–22, Boston, MA) Covalent drug discovery is entering a defining era. Once constrained by safety and selectivity concerns, advances in chemistry, screening technologies, and translational science are unlocking covalent approaches as a powerful strategy to target previously inaccessible biology. As the field evolves, the challenge is no […]

After a decade of innovation, the TPD field has its first drug approval in the form of Arvinas’ Veppanu. Combined with the recovering market of 2026, this clinical validation will unleash a new wave of innovative approaches and push TPD to a new inflection point. Already, the headwinds are reversing with $15B worth of upfront […]